Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1332 results

TAVI complications: Session 4

29 Nov 2022 – From PCR London Valves 2022

With this selection of challenging cases, discover how to face various TAVI complications, such as: annular perforation, lost wire, aortoiliac rupture, bilateral coronary ostial occlusion, and much more!

TAVI complications: Session 4

Rapid-fire clinical cases: Session 5

29 Nov 2022 – From PCR London Valves 2022

Discover a selection of cases submitted at PCR LV 2022 in this session: subacute thrombosis of a balloon-expandable aortic bioprosthesis, left axillary access for TAVI in a patient with two IMA grafts and a left side implanted pacemaker, avoiding paravalvular leak using computer simulation in bicuspid TAVI,...

Rapid-fire clinical cases: Session 5

Rapid-fire abstracts: Session 11

29 Nov 2022 – From PCR London Valves 2022

Discover a selection of abstracts presented during PCR LV 2022: the impact of cerebral embolic protection devices on acute ischaemic stroke complicating TAVI, TTVR clinical results prediction based on surgical risk scores, effects of tricuspid transcatheter edge-to-edge repair on tricuspid annular diameter, and much more!

Rapid-fire abstracts: Session 11

Rapid-fire clinical cases: Session 7

29 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: simultaneous transcatheter edge-to-edge repair of mitral and tricuspid valve, transcatheter valve implantation in mitral and tricuspid valve position, TEER failure in mitral and tricuspid position: troubleshooting approach for a rare but still eventful case,...

Rapid-fire clinical cases: Session 7

How to achieve safe early discharge

29 Nov 2022 – From PCR London Valves 2022

Discover how to achieve safe early discharge for TAVI patients with these presentations: learn more about the need of pre-procedural planning and active post-procedural care, which ECG reading are a cause for concern, and much more!

How to achieve safe early discharge

Aortic stenosis and concomitant coronary artery disease

29 Nov 2022 – From PCR London Valves 2022

Consult this session dedicated to aortic stenosis and concomitant coronary artery disease to learn how and when to screen for CAD in TAVI candidates, how to optimise your procedure to facilitate future coronary access, and to discover some tips and tricks for successful coronary angiography and PCI after TAVI.

Aortic stenosis and concomitant coronary artery disease

Aortic stenosis and concomitant mitral valve disease

29 Nov 2022 – From PCR London Valves 2022

Consult these presentations to better understand how concomitant mitral valve disease influences clinical and procedural outcomes, to differentiate between patients with mitral valve disease that require concomitant therapy and those where conservative treatment is more appropriate and to gain insights into potential interventional options for this disease.

Aortic stenosis and concomitant mitral valve disease

TAVI challenges: session 4

29 Nov 2022 – From PCR London Valves 2022

This PCR LV 2022 session includes no less than 8 cases of TAVI complications, including TAVR in iatrogenic acute native pure aortic regurgitation, TAVI in a young patient after orthotopic liver retransplantation, or percutaneous treatment of a subaortic membrane using a self-expandable TAVR.

TAVI challenges: session 4

Clinical outcomes after TAVI: Session 2

29 Nov 2022 – From PCR London Valves 2022

Consult this session on the clinical outcomes after TAVI to learn more about the first results after commercial TAVI utilising the JenaValve Trilogy system for aortic stenosis and aortic regurgitation, the outcomes of contrast-zero TAVI vs. standard practice in patients with severe renal dysfunction, and more!

Clinical outcomes after TAVI: Session 2

TAVI in TAVI

29 Nov 2022 – From PCR London Valves 2022

Discover a selection of challenging cases in this session: valve-in-valve in a previous TAVR with healed endocarditis and aortic pseudoaneurysm closure, one-year SAPIEN 3 ultra failure treated with TAV-in-TAV with an Evolut Pro+ system, transcatheter valve implantation and coronary protection in a patient with prior valve-in-valve, and...

TAVI in TAVI

The VitaFlow TAVI system - A new device that delivers exceptional patient outcomes

29 Nov 2022 – From PCR London Valves 2022

In this session, a panel of experts introduce the VitaFlow TAVI system, a good option for patients with complex anatomies. They also present the five-year results of VitaFlow in severe aortic stenosis.

The VitaFlow TAVI system

Clinical update and best practices for optimal large bore management with the MANTA closure device

29 Nov 2022 – From PCR London Valves 2022

Watch this session if you want to get an overview of the most recent clinical evidence regarding large bore closure devices and participate in a critical discussion on the most relevant clinical data and best practices in large bore management.

Clinical update and best

Optimising immediate and long-term outcomes after TAVI

29 Nov 2022 – From PCR London Valves 2022

This session addresses three important topics that impact post-procedural and long-term outcomes after performing TAVI: the impact of permanent pacemaker rates and paravalvular leak, the importance of neo-commissural alignment, and the role of cerebral embolic protection.

Optimising immediate

TAVI-in-TAVI - A road map for successful lifetime management

29 Nov 2022 – From PCR London Valves 2022

Join a team of experts that guide you through the basics of TAVI-in-TAVI, the procedural planning and techniques of implantation, followed by case examples with different index prostheses.

TAVI-in-TAVI - A road

Challenging scenarios: acute coronary obstruction

28 Nov 2022 – From PCR London Valves 2022

Discover some challenging case of acute coronary obstruction in these presentations, and learn more about the anatomical and procedural factors that predict this complication during TAVI, the available strategies for coronary protection during TAVI, as well as the leaflet laceration techniques to prevent TAVI-induced coronary obstruction.

Challenging scenarios: acute coronary obstruction

TAVI challenges: session 2

28 Nov 2022 – From PCR London Valves 2022

Watch this PCR LV 2022 session to learn how to treat TAVI with severe peripheral calcifications, a complex TAVI with extreme tortuous and horizontal aorta, or even TAVI in aortic regurgitation patient after failed attempt with commercial device. 

TAVI challenges: session 2

Is frailty still relevant after 20 years of TAVI?

28 Nov 2022 – From PCR London Valves 2022

Consult this session to gain further knowledge of the frailty syndrome, to understand its relevance in today's patient population and to learn how to measure it using validated tools.

Is frailty still relevant after 20 years of TAVI?

TAVI challenges: session 3

28 Nov 2022 – From PCR London Valves 2022

View a radial access balloon aortic valvuloplasty adapting to the challenge of small arteries, a semi-inflated buddy balloon for percutaneous TAVR in severe calcified bicuspid aortic valve, and long-term outcome of TAVR in mucopolysaccharidosis type I-HS in this PCR LV 2022 session, among others!

TAVI challenges: session 3

Clinical outcomes after TAVI: Session 1

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about clinical outcomes after TAVI thanks to a selection of abstracts submitted during PCR LV 2022: definition of transcatheter heart valve orientation in bicuspid aortic valve with the DA VINCI study, TAVI with latest device iterations in patients with very...

Clinical outcomes after TAVI: Session 1

TAVI in complex situations - LIVE case

28 Nov 2022 – From PCR London Valves 2022

  • Part 1: TAVI with the presence of a mechanical mitral valve.
    An 80-year-old female with a history of mechanical mitral valve (25 On-X in 2015) presents severe symptomatic AS with preserved LV function. The operators implant a 25 mm Navitor, with predilatation (18 mm balloon) on wire pacing...
Transcatheter intervention for aortic valve disease: state of the art